Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z PORTFOLIO -- Ignore unavailable to you. Want to Upgrade?

To: Ron McKinnon who wrote (11527)	2/12/2004 11:50:19 AM
From: Larry S.	Respond to of 11568

there have been several proposals PM'ed as to how to go forward. i agree, the zport as we have known it is dead. but hopefully we can figure out a structure where we can post trades, even if not kept track of as we have. thanks much to you and dan for the many hours of record keeping. for now. i will continue to post buys and sells that i would have for an active zport. larry

To: Ron McKinnon who wrote (11527)	2/12/2004 11:51:35 AM
From: aniela	Read Replies (2) \| Respond to of 11568

well... I think the port is over. I did like the way we did it before: posting buys and sells on the main thread. Maybe we can just do it that way ? wiesia

To: Ron McKinnon who wrote (11527)	2/12/2004 11:59:27 AM
From: Carl Worth	Read Replies (2) \| Respond to of 11568

i posted a few ideas here and got almost no response, as you said...perhaps this is why the portfolio had gotten to where it was...people seem to be worried about things like whether a stock is "real" and/or should be listed or over 5 bucks, or whether trades will be reported to the exact penny, rather than sharing and discussing ideas here's a stock i bought today just in case anyone cares: CTE company has a decent and growing business in wound care dressings and various other medical devices, and the estimate for 2004 is .19 vs .01 in 2003, so that's not bad in and of itself, but the key is the synthetic graft that they have developed and are currently testing, which could allow for people who have already had triple, quadruple, or quintuple bypasses to have additional bypasses...these people cannot currently have further bypass surgery because the first procedure uses up the available arterial material in their bodies (taken from their legs normally), so often times these people end up dying...this product could save their lives, and it could also be used in the initial bypass surgeries to eliminate the need to take artery from their legs, which adds to the potential complications of such surgery the synthetic grafts are currently being tested in brazil and have shown good results so far...i'd much rather see them being tested here, but it's easier to get such testing started there with less regulatory hurdles to jump through and less litigation risk so that is where they are starting...it will be a while before the product could come to market, but in the meantime the company as it stands is profitable carl